FGF21 negatively affects long-term female fertility in mice

OBJECTIVE: Obesity and associated liver disease are a growing public health concern. Pharmacological agents to treat non-alcoholic fatty liver disease are limited. FGF21, a hormone secreted by the liver and potent metabolic modulator, is a promising therapeutic target for this indication with severa...

Descripción completa

Detalles Bibliográficos
Autores principales: Moeckli, Beat, Pham, Thuy-Vy, Slits, Florence, Latrille, Samuel, Peloso, Andrea, Delaune, Vaihere, Oldani, Graziano, Lacotte, Stéphanie, Toso, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667250/
https://www.ncbi.nlm.nih.gov/pubmed/36406708
http://dx.doi.org/10.1016/j.heliyon.2022.e11490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9667250/
https://www.ncbi.nlm.nih.gov/pubmed/36406708
http://dx.doi.org/10.1016/j.heliyon.2022.e11490

Ejemplares similares